Preferences for Life-Prolonging Medical Treatments and Deference to the Will of God

被引:14
|
作者
Winter, Laraine [1 ]
Dennis, Marie P. [1 ]
Parker, Barbara [1 ]
机构
[1] Thomas Jefferson Univ, Ctr Appl Res Aging & Hlth, Philadelphia, PA 19107 USA
来源
JOURNAL OF RELIGION & HEALTH | 2009年 / 48卷 / 04期
关键词
Religiosity; Spirituality; Decision making; End of life; Preferences for medical interventions; RELIGIOUS INVOLVEMENT; SUSTAINING TREATMENTS; VALIDATION; SPIRITUALITY; DEPRESSION; BELIEFS; HISTORY; ADULTS;
D O I
10.1007/s10943-008-9205-y
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
We defined and measured a dimension of religiosity frequently invoked in end-of-life (EOL) research-deference to God's Will (GW)-and examined its relationship to preferences for life-prolonging treatments. In a 35-min telephone interview, 304 older men and women (60 +) were administered the 5-item GW scale, sociodemographic questions, three attitude items regarding length of life, and measures of two health indices, depression, and life-prolonging treatment preferences. The GW scale demonstrated internal consistency (Cronbach's alpha = .94) and predictive and discriminant validity. Higher scores indicative of greater deference to GW were associated with stronger life-prolonging treatment preferences in poor-prognosis scenarios. Implications for the role of religiosity in medical decision-making are discussed.
引用
收藏
页码:418 / 430
页数:13
相关论文
共 50 条
  • [41] GENDER INEQUALITIES IN MATERIAL RESOURCES, SOCIAL CONNECTEDNESS AND ATTITUDES TOWARDS LIFE-PROLONGING MEDICAL TECHNOLOGIES
    Arber, S.
    [J]. GERONTOLOGIST, 2008, 48 : 184 - 185
  • [42] The challenges of amnesia in assessing capacity, assigning a proxy, and deciding to forego life-prolonging medical treatment
    Myser, Catherine
    [J]. JOURNAL OF CLINICAL ETHICS, 2007, 18 (03): : 262 - 269
  • [43] Metastatic Prostate Cancer: Apalutamide with a life-prolonging Effect
    Kessing, Richard
    [J]. AKTUELLE UROLOGIE, 2020, 51 (01) : 10 - 10
  • [44] Multiple Myeloma From life-prolonging Therapy to Healing
    Einsele, H.
    Hoeffken, K.
    [J]. ONKOLOGE, 2018, 24 (08): : 574 - 576
  • [45] Case Commentary: Parental Request for Life-Prolonging Interventions
    Carson Strong
    [J]. HEC Forum, 2007, 19 (4) : 377 - 380
  • [46] Understanding gender differences in older people's attitudes towards life-prolonging medical technologies
    Arber, Sara
    Vandrevala, Tushna
    Daly, Tom
    Hampson, Sarah
    [J]. JOURNAL OF AGING STUDIES, 2008, 22 (04) : 366 - 375
  • [47] DEMENTIA AND THE LIFE-PROLONGING TECHNOLOGIES USED - AN ETHICAL QUESTION
    POST, SG
    WHITEHOUSE, PJ
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1992, 6 (01): : 3 - 6
  • [48] Systemic perspective of life-prolonging treatment decision making
    Shidler, S
    [J]. QUALITATIVE HEALTH RESEARCH, 1998, 8 (02) : 254 - 269
  • [49] Moral distress among nurses involved in life-prolonging treatments in patients with a short life expectancy: A qualitative interview study
    Arends, Susanne A. M.
    Steenbergen, Milou
    Thode, Maureen
    Francke, Anneke L.
    Jongerden, Irene P.
    [J]. PATIENT EDUCATION AND COUNSELING, 2022, 105 (07) : 2531 - 2536
  • [50] Feasibility and effectiveness of tools that support communication and decision making in life-prolonging treatments for patients in hospital: a systematic review
    Thode, Maureen
    Pasman, H. Roeline W.
    van Vliet, Liesbeth M.
    Damman, Olga C.
    Ket, Johannes C. F.
    Francke, Anneke L.
    Jongerden, Irene P.
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2022, 12 (03) : 262 - 269